Scott Lear

Lear’s matters of the heart

December 3, 2009

Document Tools

Print This Article

E-mail This Page

Font Size
S      M      L      XL

Related Links

Scott Lear researches heart disease—and has a To-Do List that looks long enough to cause heart disease.

The SFU kinesiologist and cardiovascular researcher has become the first Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Prevention Research at St. Paul’s Hospital, established in partnership with SFU.

There and at SFU, Lear has a truly hefty workload as he continues to investigate why people get heart disease and what they can do to prevent or manage it.

Already he has discovered that ethnicity can determine how much and where body fat is stored. As well, he has developed web-based strategies that allow rural patients to receive "virtual care" in their own homes.

His research program will continue to embrace studies of disparities in heart disease rates across different ethnic communities and further explore how technology can help to break down geographical barriers in the battle against heart disease.

The chair he now holds was established with $1.25 million from Pfizer Canada Inc., $1.128 million from St. Paul’s Hospital Foundation, $1 million from an anonymous donor, $750,000 from the Heart and Stroke Foundation of BC & Yukon and $1.5 million from SFU.


Commenting is closed
Comment Guidelines
Search SFU News Online